Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INGAP Peptide in Type 1 Diabetes
NCT00995540Phase 2Terminated
- Sponsor
- Exsulin
- Start
- Nov 2009
- Primary completion
- Dec 2011
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of INGAP peptide in type 1 diabetes mellitus (T1D), sponsored by Exsulin. Started Nov 2009; status: terminated.
02
Drugs
INGAP peptide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00995540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00995540.